Join us for a live interactive tutorial on October 29, 2020 to learn more about using our Membrane Protein Solutions.
Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies against multipass membrane proteins despite the structural complexity and low immunogenicity of these targets. Here, we present some of the lessons we have learned throughout numerous discovery campaigns against these historically intractable targets, including GPCRs, ion channels and transporters.
What you’ll learn:
The 6 key steps to success in discovering high-quality, functional MAbs
How to use Lipoparticles with native-conformation antigen for effective immunization, screening and panning
How to access conserved and difficult epitopes
October 29, 2020 at 11 a.m.